Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD   US46333X1081

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll news 
Most relevant news about IRONWOOD PHARMACEUTICALS,
11/20 IRONWOOD PHARMACEUTICALS : Earns $15 Million Milestone from Astellas upon Initia..
11/05 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 2014 Healthcare Conferenc..
11/04 IRONWOOD PHARMACEUTICALS : beats 3Q profit forecasts
11/04 IRONWOOD PHARMACEUTICALS : Initiates Phase III Trial of 72 mcg Linaclotide in Ad..
11/04 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2014 Investor Update
10/30IRONWOOD PHARMACEUTICALS, INC. : quaterly earnings release
10/30 IRONWOOD PHARMACEUTICALS : Biotech Equities Movers and Shakers - Organovo Holdin..
10/20 IRONWOOD PHARMACEUTICALS : Presents IW-9179 Phase IIa Data at American College o..
10/16 IRONWOOD PHARMACEUTICALS : Announces Initiation of Phase II Trial of Linaclotide..
10/14 IRONWOOD PHARMACEUTICALS : to Host Third Quarter 2014 Investor Update Call
09/03 IRONWOOD PHARMACEUTICALS : to Present at Morgan Stanley Global Healthcare Confer..
09/02 IRONWOOD PHARMACEUTICALS : Appoints Two New Senior Executives to Support Continu..
08/04 IRONWOOD PHARMACEUTICALS : Provides Second Quarter 2014 Investor Update
07/14 IRONWOOD PHARMACEUTICALS : Scheduled Conference Calls and Managements Changes - ..
07/07 IRONWOOD PHARMACEUTICALS : to Host Second Quarter 2014 Investor Update Call
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
11/20 IRONWOOD PHARMACEUTICALS : Earns $15 Million Milestone from Astellas upon Initia..
11/19 IRONWOOD PHARMACEUTICALS : Catabasis Names Angelika Fretzen, Ph.D., Vice Preside..
11/18 IRONWOOD PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Missouri (Nov. 1..
11/18 IRONWOOD PHARMACEUTICALS : Assigned Patent
11/12 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 2014 Healthcare Conferenc..
11/11 IRONWOOD PHARMACEUTICALS : James M. DeTore joins bluebird bio as Chief Financial..
11/10 IRONWOOD PHARMACEUTICALS : to Participate at Credit Suisse 2014 Healthcare Confe..
11/07 IRONWOOD PHARMACEUTICALS : Reports 3rd Quarter 2014 Investor Update
11/05 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 2014 Healthcare Conferenc..
11/04 IRONWOOD PHARMACEUTICALS : beats 3Q profit forecasts
11/04 IRONWOOD PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
11/04 IRONWOOD PHARMACEUTICALS : Initiates Phase III Trial of 72 mcg Linaclotide in Ad..
11/04 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2014 Investor Update
10/30IRONWOOD PHARMACEUTICALS, INC. : quaterly earnings release
10/30 IRONWOOD PHARMACEUTICALS : Biotech Equities Movers and Shakers - Organovo Holdin..
More news


Advertisement
Chart
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF